ATE119203T1 - Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. - Google Patents

Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.

Info

Publication number
ATE119203T1
ATE119203T1 AT89103859T AT89103859T ATE119203T1 AT E119203 T1 ATE119203 T1 AT E119203T1 AT 89103859 T AT89103859 T AT 89103859T AT 89103859 T AT89103859 T AT 89103859T AT E119203 T1 ATE119203 T1 AT E119203T1
Authority
AT
Austria
Prior art keywords
protein
monoclonal antibodies
immune deficiency
human immune
deficiency syndrome
Prior art date
Application number
AT89103859T
Other languages
English (en)
Inventor
Jeffrey C Hunt
George J Dawson
Virender K Sarin
Larry K Wray
Sushil G Devare
J Scott Webber
Lawrence A Falk
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE119203T1 publication Critical patent/ATE119203T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89103859T 1988-03-30 1989-03-06 Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. ATE119203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17607788A 1988-03-30 1988-03-30

Publications (1)

Publication Number Publication Date
ATE119203T1 true ATE119203T1 (de) 1995-03-15

Family

ID=22642881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89103859T ATE119203T1 (de) 1988-03-30 1989-03-06 Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.

Country Status (7)

Country Link
EP (1) EP0335134B1 (de)
JP (1) JP2954597B2 (de)
AT (1) ATE119203T1 (de)
AU (1) AU608413B2 (de)
CA (1) CA1339489C (de)
DE (1) DE68921360T2 (de)
ES (1) ES2071626T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362910A3 (de) * 1988-08-27 1991-01-09 Akzo N.V. Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
GB9410044D0 (en) * 1994-05-19 1994-07-06 Int Murex Tech Corp Assay
DE19622088A1 (de) * 1996-05-31 1997-12-04 Boehringer Mannheim Gmbh Anti-HIV-Antikörper als Kontrollproben
US6596497B1 (en) 1999-03-17 2003-07-22 New York Blood Center, Inc. Screening of antiviral compounds targeted to the HIV-1 gp41 core structure
US7744887B2 (en) 2004-06-01 2010-06-29 Merck & Co., Inc. Human antibodies interacting with HIV gp41
WO2017093985A1 (en) 2015-12-05 2017-06-08 Centre Hospitalier Universitaire Vaudois Hiv binding agents
WO2020012435A1 (en) 2018-07-13 2020-01-16 Lausanne University Hospital Hiv binding agents
JP7678790B2 (ja) 2019-07-15 2025-05-16 ローザンヌ ユニヴァーシティ ホスピタル Ｈｉｖ結合剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5831673B2 (ja) * 1979-08-22 1983-07-07 富士通株式会社 半導体記憶装置
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection

Also Published As

Publication number Publication date
JP2954597B2 (ja) 1999-09-27
EP0335134A3 (de) 1991-06-26
DE68921360T2 (de) 1995-09-28
AU608413B2 (en) 1991-03-28
AU3021989A (en) 1989-10-05
DE68921360D1 (de) 1995-04-06
EP0335134A2 (de) 1989-10-04
JPH02119794A (ja) 1990-05-07
CA1339489C (en) 1997-10-07
EP0335134B1 (de) 1995-03-01
ES2071626T3 (es) 1995-07-01

Similar Documents

Publication Publication Date Title
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
KR900700507A (ko) Htlv-1 감염 검출용 합성 펩티드 항원
ATE130681T1 (de) Bestimmung eines felinen pathogen-specifischen antikörpers und eines felinen pathogenen antigens in einem immuntest.
ATE130855T1 (de) Antikörper gegen latente proteine von menschlichen papillomavirus, diagnostische systeme und methoden.
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
DE3876496D1 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
EP0284587A3 (de) Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
DE69029134D1 (de) Monoklonale antikörper zur induzierung von toleranz
DE69133242D1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
EP0492560A3 (en) Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of hiv-1, and related peptides
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE69033260D1 (de) Intrazelluläres Antigen in einer Subpopulation von CD8+T-Lymphozyten und ein monoklonaler Antikörper spezifisch dafür
FI102834B1 (fi) Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä
DE3855761D1 (de) Verfahren und Materialien zum Nachweis und Therapie von HIV
KR920701243A (ko) T-임파 추향성 레트로 비루스 모노크로날항체
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
DE69424054D1 (de) Verwendung von antikörpern gegen beta-2-mikroglobulin-freie klasse-i-hla-molekülen zum erhalt eines diagnostischen hiv-tests und zusammensetzungen mit schutzwirkung gegen hiv-infektionen
Knowles IMMUNOCHEMICAL CHARACTERIZATION OF MONOCLONAL ANTIBODIES TO FACTORS IN HISTOPLASMIN.
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties